Is UnitedHealth Group (UNH) a Buy Right Now?
A plain-English read on UnitedHealth Group stock — what the chart and the numbers are saying today, with no jargon and no hype.
What this means, in plain English
UnitedHealth Group is currently trading at $420.74, which is above its 200-day average of $344.72. This long-term average acts as a baseline for price health. When a stock sits above this level, it often signals that the overall trend remains positive for the company.
The RSI, or Relative Strength Index—a gauge of whether a stock has climbed too far, too fast—is at 50.1. This number is neutral, meaning the stock is not currently overbought or oversold. With the price sitting above the 50-day average of $410.26, the momentum appears to be moving in a constructive direction.
Should you buy UnitedHealth Group stock?
Deciding to buy depends on your personal goals and comfort with risk. Given that the price is currently holding above key averages and shows a neutral RSI, the data supports a buy position for those looking to enter at current levels.
Is UNH a good stock for beginners?
UnitedHealth Group is a large, established company, which can offer more stability than smaller, speculative stocks. However, all stocks carry risk, and the P/E ratio of 32 suggests investors are paying a premium for these earnings, so patience is always a virtue.
What's driving UNH right now
The stock price of $420.74 is comfortably above its 200-day average of $344.72.
The stock has found recent support, or a price floor, at $414.37.
The P/E ratio of 32 indicates the market is pricing the stock at a higher multiple relative to its earnings.
The stock faces recent resistance, or a price ceiling, at $461.62.
What UnitedHealth Group actually does
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services with patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, public entities, life sciences companies and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease and drug therapy management. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; Medicaid plans, including Temporary Assistance to Needy Families; Children's Health Insurance Programs; Dual SNPs; Long-Term Services and Supports; Aged, Blind and Disabled; and other federal, state, and community health care programs. and health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. UnitedHealth Group Incorporated was founded in 1974 and is based in Eden Prairie, Minnesota.
UnitedHealth Group by the numbers
Wall Street consensus on UNH is Buy. That is the analyst community's view, shown for context — it is not our read and not a recommendation.
Who owns UnitedHealth Group?
Institutions — pension funds, asset managers, index providers — hold 86.2% of UNH, and the concentration matters: the largest single holder alone controls 8.09% of the company.
| Holder | Shares | % held |
|---|---|---|
| 73.47M | 8.09% | |
| 58.87M | 6.48% | |
| 45.33M | 4.99% |
Names withheld — plus 3 more records not shown.
See who owns itWhat UnitedHealth Group insiders have been doing
Executives and directors must disclose their own trades in company stock. Of the last 6 disclosed transactions we hold for UnitedHealth Group, none were an open-market buy or sell — they are awards, vesting, option exercises or derivative conversions, which is normal and says nothing about conviction either way. Insiders sell for many ordinary reasons — scheduled plans, tax, diversification — so a sale is not by itself a signal.
| Insider | Date | Type | Shares | Value |
|---|---|---|---|---|
| 2026-07-01 | AWARD / VEST | 220 | — | |
| 2026-07-01 | AWARD / VEST | 206 | — | |
| 2026-07-01 | AWARD / VEST | 220 | — |
Names withheld — plus 3 more records not shown.
See which insidersThe numbers behind the read
Who in Washington has been trading UNH?
Members of Congress must disclose trades over $1,000 within 45 days under the STOCK Act. At least 25 disclosures name UNH — filed by 10 separate members or more and worth $400K–$1.10M combined (filings report bands, never exact amounts). 17 purchase-side, 8 sale-side, most recently on 2026-07-10.
| Member | Date | Action | Amount filed |
|---|---|---|---|
| 2026-07-10 | SELL | $1,001 - $15,000 | |
| 2026-06-12 | SELL | $1,001 - $15,000 | |
| 2026-06-12 | SELL | $1,001 - $15,000 |
Names withheld — plus 22 more records not shown.
See which membersWith the price holding above its 200-day average and a neutral RSI, UnitedHealth Group presents a clear buy signal for disciplined investors.
Don't guess. Practice this trade first.
Buy it with virtual cash and watch how it plays out — before a dollar of your own is on the line.
Practice UNH risk-free in your paper portfolioPaper trading, the AI Read & live indicators are inside a Money GPS membership — one price, the whole platform.
Beginner questions about UNH
Should I buy UNH stock?+
The data shows a buy signal as the price of $420.74 sits above the 200-day average of $344.72.
Is UNH a good long-term investment?+
While no investment is guaranteed, the stock is currently trending upward by staying above its 200-day average of $344.72.
Is UNH a buy or a sell?+
Based on the current technical setup and the price of $420.74, the verdict is a buy.
Is UNH overvalued?+
The P/E ratio of 32 suggests the stock is priced at a premium, though it remains within its 52-week range of $239.5 to $461.62.
Is UNH a good stock for beginners?+
As a large company, it may be suitable for beginners, though the P/E ratio of 32 is a factor to consider.
Important disclaimer
This page is for educational and informational purposes only and is not financial, investment, tax, or legal advice, nor a recommendation, offer, or solicitation to buy, sell, or hold UnitedHealth Group (UNH) or any other security. The Money GPS is not a registered investment adviser, broker-dealer, or financial planner, and no content here should be relied upon to make an investment decision.
The verdict, indicators, and commentary are generated automatically — in part using AI — from third-party market data (via Yahoo Finance) that may be delayed, incomplete, or inaccurate, and is provided “as is” without any warranty. Figures reflect the market as of 2026-07-24 and change constantly; the read above may already be out of date. A “Buy,” “Hold,” or “Be Careful” label is a simplified, rules-based signal for beginners — not a price target or a guarantee of any outcome.
All investing involves risk, including the possible loss of your entire principal. Past performance and historical patterns do not guarantee future results. Always do your own research and consult a licensed financial professional who knows your personal circumstances before investing. You are solely responsible for your own investment decisions. The Money GPS and its authors may hold positions in the securities discussed and accept no liability for any loss arising from the use of this information.